School of Veterinary Science at The University of Queensland, UQ Gatton Campus, Gatton, Queensland, Australia.
College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA.
Equine Vet J. 2024 Mar;56(2):243-252. doi: 10.1111/evj.13981. Epub 2023 Aug 3.
Equine thyroid disorders pose a diagnostic challenge in clinical practice because of the effects of nonthyroidal factors on the hypothalamic-pituitary-thyroid axis, and the horse's ability to tolerate wide fluctuations in thyroid hormone concentrations and survive without a thyroid gland. While benign thyroid tumours are common in older horses, other disorders like primary hypothyroidism or hyperthyroidism in adult horses and congenital hypothyroidism in foals are rare. There is a common misunderstanding regarding hypothyroidism in adult horses, especially when associated with the clinical profile of obesity, lethargy, and poor performance observed in dogs and humans. Low blood thyroid hormone concentrations are often detected in horses as a secondary response to metabolic and disease states, including with the nonthyroidal illness syndrome; however, it is important to note that low thyroid hormone concentrations in these cases do not necessarily indicate hypothyroidism. Assessing equine thyroid function involves measuring thyroid hormone concentrations, including total and free fractions of thyroxine (T4) and triiodothyronine (T3); however, interpreting these results can be challenging due to the pulsatile secretion of thyroid hormones and the many factors that can affect their concentrations. Dynamic testing, such as the thyrotropin-releasing hormone stimulation test, can help assess the thyroid gland response to stimulation. Although true hypothyroidism is extremely rare, thyroid hormone supplementation is commonly used in equine practice to help manage obesity and poor performance. This review focuses on thyroid gland pathophysiology in adult horses and foals, interpretation of blood thyroid hormone concentrations, and evaluation of horses with thyroid disorders. It also discusses the use of T4 supplementation in equine practice.
马的甲状腺疾病在临床实践中构成了诊断挑战,这是由于非甲状腺因素对下丘脑-垂体-甲状腺轴的影响,以及马能够耐受甲状腺激素浓度的广泛波动并在没有甲状腺的情况下存活。虽然良性甲状腺肿瘤在老年马中很常见,但其他疾病,如成年马的原发性甲状腺功能减退症或甲状腺功能亢进症以及驹的先天性甲状腺功能减退症则较为罕见。人们对成年马的甲状腺功能减退症存在一个常见的误解,特别是当它与肥胖、嗜睡和运动表现不佳的临床特征有关时,这种情况在狗和人类中也存在。马的血液甲状腺激素浓度通常因代谢和疾病状态而降低,包括非甲状腺疾病综合征,但重要的是要注意,在这些情况下,甲状腺激素浓度降低并不一定表示甲状腺功能减退症。评估马的甲状腺功能包括测量甲状腺激素浓度,包括总甲状腺素(T4)和三碘甲状腺原氨酸(T3)的游离和结合分数;然而,由于甲状腺激素的脉冲式分泌以及许多可能影响其浓度的因素,解释这些结果具有挑战性。动态测试,如促甲状腺激素释放激素刺激试验,可以帮助评估甲状腺对刺激的反应。虽然真正的甲状腺功能减退症极为罕见,但在马的临床实践中,甲状腺激素补充通常用于帮助管理肥胖和运动表现不佳。这篇综述重点介绍了成年马和驹的甲状腺生理、血液甲状腺激素浓度的解释以及甲状腺疾病马的评估,还讨论了 T4 补充在马临床实践中的应用。